Status:

UNKNOWN

Peri-capsular Nerve Group Block Versus Fascia Iliaca Block for Hip Arthroplasty

Lead Sponsor:

Cairo University

Conditions:

Post Operative Pain Management

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

In this study, the investigator will examine the efficacy of Pericapsular nerve group (PENG) block in hip surgeries as a post-operative pain management technique in comparison with fascia Iliaca block...

Detailed Description

Hip fracture is a common orthopedic emergency in the elderly, and it is associated with significant morbidity and mortality.1 Surgical reduction and fixation are the definitive treatment in most patie...

Eligibility Criteria

Inclusion

  • Patients scheduled for hip replacement surgeries e.g. hip hemiarthroplasty, total hip arthroplasty under subarachnoid block (SAB)

Exclusion

  • Coagulopathy
  • infection at the injection site
  • allergy to local anesthetics
  • severe cardiopulmonary disease (≥ASA IV)
  • diabetic or other neuropathies
  • patients receiving opioids for chronic analgesic therapy
  • contraindication to spinal anesthesia
  • inability to comprehend visual analog scale (VAS).

Key Trial Info

Start Date :

February 15 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 20 2019

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT03783247

Start Date

February 15 2019

End Date

June 20 2019

Last Update

December 21 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cairo University

Cairo, Giza Governorate, Egypt, 1234